355 results on '"Hoshide, S."'
Search Results
2. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS).
- Author
-
Kario K, Kai H, Rakugi H, Hoshide S, Node K, Maekawa Y, Tsutsui H, Sakata Y, Aoki J, Nanto S, and Yokoi H
- Subjects
- Humans, Antihypertensive Agents therapeutic use, East Asian People, Japan, Societies, Medical, Sympathectomy, Consensus, Denervation methods, Hypertension therapy, Kidney innervation
- Abstract
This is the first consensus statement of the Joint Committee on Renal Denervation of the Japanese Society of Hypertension (JSH)/Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)/Japanese Circulation Society (JCS). The consensus is that the indication for renal denervation (RDN) is resistant hypertension or "conditioned" uncontrolled hypertension, with high office and out-of-office blood pressure (BP) readings despite appropriate lifestyle modification and antihypertensive drug therapy. "Conditioned" uncontrolled hypertension is defined as having one of the following: (1) inability to up-titrate antihypertensive medication due to side effects, the presence of complications, or reduced quality of life. This includes patients who are intolerant of antihypertensive drugs; or (2) comorbidity at high cardiovascular risk due to increased sympathetic nerve activity, such as orthostatic hypertension, morning hypertension, nocturnal hypertension, or sleep apnea (unable to use continuous positive airway pressure), atrial fibrillation, ventricular arrythmia, or heart failure. RDN should be performed by the multidisciplinary Hypertension Renal Denervation Treatment (HRT) team, led by specialists in hypertension, cardiovascular intervention and cardiology, in specialized centers validated by JSH, CVIT, and JCS. The HRT team reviews lifestyle modifications and medication, and the patient profile, then determines the presence of an indication of RDN based on shared decision making with each patient. Once approval for real-world clinical use in Japan, however, the joint RDN committee will update the indication and treatment implementation guidance as appropriate (annually if necessary) based on future real-world evidence., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
3. Preface-risk of hypertension to cardiovascular disease and beneficial effects of drugs.
- Author
-
Mogi M, Hoshide S, and Kario K
- Subjects
- Humans, Hypertension drug therapy, Cardiovascular Diseases prevention & control, Antihypertensive Agents therapeutic use
- Published
- 2024
- Full Text
- View/download PDF
4. Hypertension in Asia: Genetic, lifestyle, and clinical insights.
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Asia epidemiology, Life Style, Hypertension genetics, Hypertension epidemiology
- Published
- 2024
- Full Text
- View/download PDF
5. Hypertension treatment up-date on World Hypertension Day 2024: current status and future prospects in Asia.
- Author
-
Kario K, Hoshide S, and Mogi M
- Subjects
- Humans, Asia epidemiology, Antihypertensive Agents therapeutic use, Global Health, Hypertension drug therapy, Hypertension epidemiology
- Published
- 2024
- Full Text
- View/download PDF
6. Consider hypertension risk factors once again.
- Author
-
Mogi M, Hoshide S, and Kario K
- Subjects
- Humans, Risk Factors, Hypertension epidemiology
- Published
- 2024
- Full Text
- View/download PDF
7. Clinical studies on pharmacological treatment of hypertension in Japan.
- Author
-
Kario K, Hoshide S, Yamamoto K, Okura A, and Rakugi H
- Subjects
- Humans, Japan epidemiology, Blood Pressure drug effects, Practice Guidelines as Topic, Treatment Outcome, Blood Pressure Monitoring, Ambulatory, Hypertension drug therapy, Hypertension epidemiology, Antihypertensive Agents therapeutic use
- Abstract
Differences in the epidemiology and phenotypes of hypertension in Japan compared with Western countries mean that optimal approaches to the pharmacological management of hypertension should be based on local data. Fortunately, there is a large body of evidence from studies conducted in Japanese populations to inform guidelines and treatment decisions. This article highlights treatment recommendations and BP targets for Japanese patients with hypertension, and summarizes key literature supporting these recommendations. The latest version of the Japanese Society of Hypertension (JSH) guidelines is consistent with US and European guidelines in recommending that the general BP target should be <130/80 mmHg for office blood pressure (BP) and <125/75 mmHg for home BP. There is good local evidence to support these targets. The JSH guidelines also strongly recommend that antihypertensive therapy is managed and monitored based on home BP, due to the closer association of this parameter with cardiovascular risk compared with office BP. Japan is a leader in out-of-office BP research, meaning that there is good evidence for the Japanese recommendations. Key features of antihypertensive agents for use in Japanese patients with hypertension include the ability to reduce stroke risk provide antihypertensive efficacy throughout the 24-h dosing period. Calcium channel blockers appear to be particularly effective in Asian populations, and are the most commonly prescribed agents in Japan. Again consistent with international recommendations, antihypertensive therapy should be started with a combination of agents to maximize the chances of achieving target BP., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2024
- Full Text
- View/download PDF
8. Original article and review highlighted in this month of Hypertension Research.
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Hypertension physiopathology
- Published
- 2024
- Full Text
- View/download PDF
9. Hypertension facilitates age-related diseases. ~ Is hypertension associated with a wide variety of diseases?~.
- Author
-
Mogi M, Ikegawa Y, Haga S, Hoshide S, and Kario K
- Subjects
- Humans, Vascular Diseases pathology, Animals, Aging pathology, Hypertension physiopathology
- Abstract
Hypertension, a disease whose prevalence increases with age, induces pathological conditions of ischemic vascular disorders such as cerebral infarction and myocardial infarction due to accelerated arteriosclerosis and circulatory insufficiency of small arteries and sometimes causes hemorrhagic conditions such as cerebral hemorrhage and ruptured aortic aneurysm. On the other hand, as it is said that aging starts with the blood vessels, impaired blood flow associated with vascular aging is the basis for the development of many pathological conditions, and ischemic changes in target organs associated with vascular disorders result in tissue dysfunction and degeneration, inducing organ hypofunction and dysfunction. Therefore, we hypothesized that hypertension is associated with all age-related vascular diseases, and attempted to review the relationship between hypertension and diseases for which a relationship has not been previously well reported. Following our review, we hope that a collaborative effort to unravel age-related diseases from the perspective of hypertension will be undertaken together with experts in various specialties regarding the relationship of hypertension to all pathological conditions., (© 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
10. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy.
- Author
-
Kario K, Okura A, Hoshide S, and Mogi M
- Subjects
- Humans, Antihypertensive Agents therapeutic use, Hypertension drug therapy, World Health Organization, Global Health
- Abstract
Thirty-year % increase of adults with hypertension in the European/ Americas and South-East Asia/ Western Pacific (WHO region). Create using the data from: World Health Organization. Global report on hypertension: the race against a silent killer. Geneva, Switzerland: 2023., (© 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
11. Could wristwatch-type wearable oscillometric blood pressure monitoring be a third option for out-of-office blood pressure monitoring?
- Author
-
Tomitani N, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure Monitoring, Ambulatory, Blood Pressure physiology, Blood Pressure Determination, Hypertension diagnosis, Hypertension physiopathology, Wearable Electronic Devices
- Published
- 2024
- Full Text
- View/download PDF
12. Systemic hemodynamic atherothrombotic syndrome: from hypothesis to evidence.
- Author
-
Ishiyama Y, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure Monitoring, Ambulatory, Blood Pressure physiology, Hemodynamics, Risk Factors, Hypertension complications, Cardiovascular Diseases etiology
- Abstract
Hypertension is a risk factor for cardiovascular disease (CVD). However, the association between blood pressure (BP) and CVD events has been based on mean BP alone. BP variability (BPV) is associated with increased organ damage and CVD events independently or beyond average home BP. To explain this association, we propose the systemic hemodynamic atherothrombotic syndrome (SHATS) hypothesis. The SHATS hypothesis indicates that hemodynamic stress increases vascular disease and vice versa, leading to a vicious cycle of the association between hemodynamic stress and a vascular disease; this association provides not only the risk but also the trigger for CVD events. The evidences of SHATS were gradually accumulating. We showed arterial stiffness synergistically amplified the association between hemodynamic stress and cardiac overload / CVD events in patients with at least one CVD risk factor., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
13. Cognitive impairment in heart failure patients: association with abnormal circadian blood pressure rhythm: a review from the HOPE Asia Network.
- Author
-
Komori T, Hoshide S, Turana Y, Sogunuru GP, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Circadian Rhythm physiology, Blood Pressure Monitoring, Ambulatory, Heart Failure complications, Cognitive Dysfunction complications, Atherosclerosis complications, Hypertension
- Abstract
Cognitive impairment (CI) is frequently a comorbid condition in heart failure (HF) patients, and is associated with increased cardiovascular events and death. Numerous factors contribute to CI in HF patients. Decreased cerebral blood flow, inflammation, and activation of neurohumoral factors are all thought to be factors that exacerbate CI. Hypoperfusion of the brain due to decreased systemic blood flow, cerebral venous congestion, and atherosclerosis are the main mechanism of CI in HF patients. Abnormal circadian BP rhythm is one of the other conditions associated with CI. The conditions in which BP does not decrease sufficiently or increases during the night are called non-dipper or riser BP patterns. Abnormal circadian BP rhythm worsens CI in HF patients through cerebral congestion during sleep and atherosclerosis due to pressure overload. Interventions for CI in HF patients include treatment for HF itself using cardiovascular drugs, and treatment for fluid retention, one of the causes of abnormal circadian rhythms. Proposed pathways of cognitive impairment in heart failure through abnormal circadian blood pressure rhythm., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
14. Intriguing review and topics in this month of Hypertension Research.
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Hypertension drug therapy, Alzheimer Disease, Cognitive Dysfunction
- Published
- 2024
- Full Text
- View/download PDF
15. The importance of regular home blood pressure monitoring over the life course.
- Author
-
Tomitani N, Hoshide S, and Kario K
- Subjects
- Humans, Female, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Life Change Events, Risk Factors, Blood Pressure Determination, Heart Disease Risk Factors, Cardiovascular Diseases, Hypertension physiopathology
- Published
- 2024
- Full Text
- View/download PDF
16. Nighttime blood pressure and glucose control impacts on left ventricular hypertrophy: The Japan Morning Surge Home Blood Pressure (J-HOP) Study.
- Author
-
Toriumi S, Hoshide S, Kabutoya T, and Kario K
- Subjects
- Adult, Humans, Middle Aged, Aged, Blood Pressure physiology, Hypertrophy, Left Ventricular complications, Blood Glucose, Japan, Blood Pressure Monitoring, Ambulatory, Hypertension complications, Diabetes Mellitus
- Abstract
Several studies investigated the association between nighttime blood pressure (BP) and left ventricular hypertrophy (LVH) in diabetes, but since most of these studies were conducted in diabetes populations only, they did not compare differences in the impact of nighttime BP on LVH in subjects without diabetes. Moreover, data about the impact of glucose control in diabetes on the relationship between nighttime BP and LVH are sparse. We classified 1277 adults (age 64.7 ± 11.8 years) performing ambulatory BP monitoring while enrolled as part of the Japan Morning Surge Home Blood Pressure (J-HOP) study into groups according to the control status of daytime BP (systolic BP [SBP] < 135 mmHg or ≥135 mmHg), nighttime BP (SBP < 120 mmHg or ≥120 mmHg), and diabetes (HbA1c < 7.0% or ≥7.0%). LVH was assessed by echocardiography. LVH according to echocardiographic criteria was identified in 33.7% of the participants. The group with poorly controlled diabetes plus uncontrolled nighttime BP (n = 90) had a 2.1-fold higher risk of LVH compared to the group with controlled nighttime BP and non-diabetes (n = 505) (odds ratio [OR] 2.10, 95% confidence interval [CI]: 1.29-3.44). No association was observed between uncontrolled daytime BP and diabetes for LVH. In the participants with poorly controlled diabetes (n = 146), uncontrolled nighttime BP posed a 3.1-fold higher risk of LVH compared to controlled nighttime BP (OR 3.12, 95%CI: 1.47-6.62). This association was not found in controlled diabetes. Uncontrolled nighttime BP was associated with a risk of LVH, especially among individuals with poorly controlled diabetes., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
17. Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended.
- Author
-
Kario K, Okawara Y, Kanegae H, and Hoshide S
- Subjects
- Humans, Aged, Blood Pressure physiology, Risk Factors, Blood Pressure Monitoring, Ambulatory, Heart Disease Risk Factors, Cardiovascular Diseases diagnosis, Cardiovascular Diseases epidemiology, Cardiovascular Diseases etiology, Coronary Artery Disease diagnosis, Coronary Artery Disease epidemiology, Hypertension complications, Hypertension diagnosis, Hypertension drug therapy, Stroke epidemiology, Stroke etiology, Stroke prevention & control, Heart Failure diagnosis, Heart Failure epidemiology, Heart Failure complications, Aortic Dissection
- Abstract
Background: The long-term benefit of achieving the Japanese Society of Hypertension home systolic blood pressure (SBP) target of <125 mm Hg has not been fully evaluated. This study investigated the long-term risk of cardiovascular disease events in individuals with home SBP <125 versus 125 to <135 or ≥135 mm Hg who participated in the J-HOP study (Japan Morning Surge-Home Blood Pressure)., Methods: The J-HOP study enrolled outpatients with ≥1 cardiovascular risk factor between 2005 and 2012, with follow-up until March 2015 and extended follow-up from December 2017 to May 2018. Cardiovascular disease events (stroke, coronary artery disease, congestive heart failure, and aortic dissection) were compared between home SBP subgroups., Results: During mean 5.9 years of follow-up in 4231 participants (mean age, 65 years), cardiovascular events included stroke (n=89), coronary artery disease (n=116), congestive heart failure (n=37), and aortic dissection (n=8). The adjusted 10-year risk of total cardiovascular disease was slightly higher, and stroke risk was significantly higher when baseline home SBP was ≥135 versus <125 mm Hg (adjusted hazard ratio, 1.39 [95% CI, 0.97-2.00] for overall cardiovascular disease and 2.68 [95% CI, 1.34-5.38] for stroke; this was largely due to between-group differences in the first 5 years of follow-up, which were maintained over the subsequent 5 years). Findings were similar in the subgroup of high-risk patients (those with diabetes or stroke history)., Conclusions: These data highlight the potential long-term benefit of strict home SBP control and validate this as an appropriate Japanese Society of Hypertension guideline target although confirmation in larger populations is needed., Registration: URL: https://www.umin.ac.jp/ctr/; University Hospital Medical Information Network Clinical Trials Registry; Unique identifier: UMIN000000894 (Japan Morning Surge-Home Blood Pressure study)., Competing Interests: Disclosures K. Kario received research funding from Omron Healthcare Co, Fukuda Denshi, and A&D Co. The other authors report no conflicts.
- Published
- 2024
- Full Text
- View/download PDF
18. Prognosis of a malignant phenotype of obesity defined by a cardiac biomarker in hypertension: the Japan Morning Surge-Home Blood Pressure study.
- Author
-
Watanabe H, Hoshide S, Kanegae H, and Kario K
- Subjects
- Humans, Japan epidemiology, Blood Pressure, Prognosis, Obesity complications, Biomarkers, Phenotype, Peptide Fragments, Troponin T, Natriuretic Peptide, Brain, Hypertension complications, Cardiovascular Diseases complications
- Abstract
Obesity with increased high-sensitive cardiac troponin T (hs-cTnT) has been reported to be more likely to progress cardiovascular disease (CVD) events, which suggests that hs-cTnT may identify a "malignant" phenotype of obesity. We classified 3513 hypertensive patients from the Japan Morning Surge-Home Blood Pressure (J-HOP) study into groups based on body mass index (BMI) (normal weight: <25 kg/m
2 , overweight: 25-29.9 kg/m2 , obesity: ≥30 kg/m2 ) and elevations in biomarker levels (hs-cTnT ≥3 ng/mL: 51.3%, 54.9%, 53.3%, and N-terminal pro-brain natriuretic peptide [NT-ProBNP] ≥55 pg/mL: 51.1%, 40.7%, 36.0% in each BMI category). We evaluated the independent and combined associations of BMI and each hs-cTnT/NT-proBNP or both with CVD events (fatal and nonfatal coronary artery disease, stroke, and hospitalized heart failure). During the mean 6.4 ± 3.9-year follow-up, 232 CVD events occurred. Obesity with elevated hs-cTnT was associated with a risk of CVD events compared to normal weight without elevated hs-cTnT (hazard ratio 3.22, 95% confidence interval: 1.83-5.68). A similar pattern of results was also observed across the status of obesity and elevated NT-proBNP. There was a significant interaction between hs-cTnT and CVD events according to the obesity status (p = 0.039), while this association was marginal in NT-proBNP (p = 0.060). The magnitude of the mediation of hs-cTnT for the association between obesity and CVD risk was 41.2%, and that for NT-proBNP was 8.1%. In this Japanese hypertensive population, the elevation of hs-cTnT identified obese patients at particularly high risk for developing CVD events, suggesting that hs-cTnT may identify a 'malignant' phenotype of obesity., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)- Published
- 2024
- Full Text
- View/download PDF
19. 2023 update and perspectives.
- Author
-
Mogi M, Tanaka A, Node K, Tomitani N, Hoshide S, Narita K, Nozato Y, Katsurada K, Maruhashi T, Higashi Y, Matsumoto C, Bokuda K, Yoshida Y, Shibata H, Toba A, Masuda T, Nagata D, Nagai M, Shinohara K, Kitada K, Kuwabara M, Kodama T, and Kario K
- Subjects
- Humans, Journal Impact Factor, Hypertension therapy
- Abstract
Total 276 manuscripts were published in Hypertension Research in 2022. Here our editorial members picked up the excellent papers, summarized the current topics from the published papers and discussed future perspectives in the sixteen fields. We hope you enjoy our special feature, 2023 update and perspectives in Hypertension Research., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
20. Home blood pressure measurement consistency and cognitive impairment.
- Author
-
Hoshide S, Nishizawa M, Kanegae H, and Kario K
- Subjects
- Humans, Aged, Aged, 80 and over, Blood Pressure, Antihypertensive Agents therapeutic use, Blood Pressure Monitoring, Ambulatory, Hypertension, Cognitive Dysfunction diagnosis, Cardiovascular Diseases drug therapy
- Abstract
Cognitive function tends to decline with age, and individuals with mild cognitive impairment (MCI) often have difficulty completing established self-management tasks. The aim of this study was to investigate the association between the number of days within a 5-and-a-half-day period that patients took their home blood pressure (BP) as instructed and MCI assessed by the Japanese version of the Montreal Cognitive Assessment (MoCA-J) in an elderly clinical population. We analyzed 303 ambulatory patients (mean age 77.3 ± 8.2 years) in whom MoCA-J had been assessed, who were instructed to take home BP for 1 evening and twice a day for the next five days, and who had at least one morning home BP measurement. After accounting for patient characteristics including age, sex, body mass index, drinking, smoking, prevalent cardiovascular disease, morning systolic BP and diastolic BP, and the use of antihypertensive drugs, the number of days home BP was measured was independently associated with both total MoCA-J score (estimate, 0.82; 95% confidence interval [CI], 0.43-1.21; P < 0.001) and the lowest quartile of MoCA-J score (13 or below) (odds ratio [OR], 0.72; 95%CI, 0.59-0.87; P = 0.001). Home BP measurement noncompliance (<5 days' measurement) was also independently associated with the total MoCA-J score (estimate, -2.56; 95%CI, -4.09 to -1.03; P = 0.001) and the lowest quartile of MoCA-J score (OR, 3.32; 95%CI, 1.59-6.96; P = 0.001). In conclusion, poor compliance with home BP monitoring was associated with cognitive impairment in elderly cases who had been specifically instructed to perform home BP monitoring during a designated period., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
21. Home systolic blood pressure time in therapeutic range and cardiovascular risk: the practitioner-based nationwide J-HOP study extended.
- Author
-
Kario K, Tomitani N, Okawara Y, Kanegae H, and Hoshide S
- Subjects
- Humans, Aged, Blood Pressure physiology, Risk Factors, Blood Pressure Monitoring, Ambulatory, Heart Disease Risk Factors, Hypertension complications, Hypertension drug therapy, Hypertension epidemiology, Cardiovascular Diseases etiology, Cardiovascular Diseases complications, Stroke
- Abstract
Time in therapeutic range (TTR) for office systolic blood pressure (SBP) is an independent predictor of major cardiovascular events. However, the clinical implications of TTR for home SBP have not yet been investigated. This study determined the association between TTR of home SBP and cardiovascular events in individuals with ≥1 cardiovascular risk factor who were enrolled in The Japan Morning Surge-Home Blood Pressure (J-HOP) study. The therapeutic range for home SBP was defined as home SBP of 100-135 mmHg during the 13-day baseline period of the J-HOP study. Participants were divided into subgroups based on quartiles of TTR for home SBP, and the risk of cardiovascular events was determined in each quartile. During a mean 6.3 years of follow-up in 4070 participants (mean age 65 years), cardiovascular events included stroke in 92, coronary artery disease in 119, heart failure in 41 and aortic dissection in 8. The adjusted hazard ratio (95% confidence interval) for the risk of total cardiovascular events in participants with home SBP TTR in the lowest (100%) versus highest quartile (<15.3%) was 1.74 (1.16-2.61); the corresponding hazard ratio for stroke events was 2.11 (1.06-4.21). A 10% decrease in home SBP TTR was associated with a 4% increase in the risk of total cardiovascular events (p = 0.033) and a 9% increase in the risk of stroke (p = 0.004). The significant association seen between home SBP TTR and the occurrence of cardio- and cerebrovascular events highlights the importance of achieving stable reductions in home SBP and minimizing day-by-day home BP variability.Clinical Trial Registration: University Hospital Medical Information Network Clinical Trials Registry, UMIN000000894 (J-HOP study)., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2024
- Full Text
- View/download PDF
22. Agreement Between Guideline Thresholds Using an "All-in-One" Device to Measure Office, Home, and Ambulatory Blood Pressures.
- Author
-
Kario K, Tomitani N, Hoshide S, Nishizawa M, Yoshida T, Kabutoya T, Fujiwara T, and Mizuno H
- Subjects
- Humans, Blood Pressure physiology, Prospective Studies, Blood Pressure Determination, Blood Pressure Monitoring, Ambulatory methods, Hypertension diagnosis
- Abstract
Background: Blood pressure (BP) thresholds for diagnosing and managing hypertension vary for office, home, and ambulatory readings, and between guideline documents. This analysis determined corresponding office, home, and ambulatory BP thresholds using baseline data from the HI-JAMP (Home-Activity Information and Communication Technology-Based Japan Ambulatory Blood Pressure Monitoring Prospective) study, which used a validated "all-in-one" BP monitoring device., Methods and Results: Data from 2322 treated patients with hypertension who underwent office BP measurement, then 24-hour ambulatory BP monitoring, then home BP monitoring for 5 days were analyzed. Corresponding BP thresholds for office, home, and ambulatory measurements were determined using Deming regression. Values equivalent to office systolic BP (SBP) of 120 and 140 mm Hg were as follows: 115.9 and 127.7 mm Hg for 24-hour ambulatory SBP; 120.8 and 134.0 mm Hg for daytime ambulatory SBP; 104.9 and 117.9 mm Hg for nighttime ambulatory SBP; and 122.0 and 134.2 mm Hg for morning-evening average home SBP. Deming regression showed that morning-evening average home SBP and daytime ambulatory SBP were almost the same (home SBP=0.99×daytime ambulatory SBP+0.27 mm Hg; r =0.627). Morning-evening average home SBP values of 120 and 135 mm Hg were equivalent to daytime ambulatory SBP values of 119.1 and 133.9 mm Hg, respectively. A home SBP threshold of 130 mm Hg corresponded to 24-hour and nighttime ambulatory SBP values of 123.5 and 113.6 mm Hg, whereas a home SBP threshold of 135 mm Hg corresponded to 24-hour and nighttime ambulatory SBP values of 128.0 and 119.2 mm Hg., Conclusions: Ambulatory and home BP thresholds in this analysis were similar to those proposed by existing guidelines. The similarity between the home BP and daytime ambulatory BP thresholds was a clinically relevant finding.
- Published
- 2023
- Full Text
- View/download PDF
23. Comparison of Ambulatory and Home Blood Pressure Variability for Cardiovascular Prognosis and Biomarkers.
- Author
-
Narita K, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Prognosis, Blood Pressure Monitoring, Ambulatory, Biomarkers, Hypertension diagnosis
- Abstract
Background: Although blood pressure variability (BPV) is reported to be associated with cardiovascular prognoses, it has not been established whether ambulatory BPV (ABPV; ie, short-term 24-hour BPV) or home BPV (HBPV; day-to-day BPV) is a superior clinical marker., Methods: We analyzed the associations of ABPV and HBPV with cardiovascular prognoses and biomarkers in 1314 hypertensive outpatients who underwent both home and ambulatory BP measurements in the J-HOP study (Japan Morning-Surge Home Blood Pressure). BPV was evaluated by the SD, coefficient of variation, and average real variability of the patients' 24-hour ambulatory and home systolic BP values., Results: During the median 7.0-year follow-up, 109 cardiovascular events occurred. All SD, coefficient of variation, and average real variability values of the HBPV were significantly associated with cardiovascular risk even after adjusting by average 24-hour ambulatory systolic BP and each ABPV value: 1 SD of hazard ratio (95% CI) for the SD, 1.36 (1.14-1.63); coefficient of variation, 1.38 (1.16-1.66); and average real variability 1.29 (1.10-1.51) of HBPV. The ABPV parameters did not exhibit comparable relationships. The cardiovascular risk spline curves showed a trend toward increased risks with increasing HBPV parameters. There were no differences between ABPV and HBPV in the relationships with B-type natriuretic peptide and the urine albumin-creatine ratio., Conclusions: In this comparative analysis of ambulatory and home BP monitoring values in individuals with hypertension, ABPV was not significantly associated with cardiovascular prognosis adjusted by average BP level, and HBPV was suggested to have modest superiority in predicting cardiovascular prognosis compared with ABPV., Competing Interests: Disclosures K. Kario has received research funding from Omron Healthcare Co., Fukuda Denshi, and A&D Co. The other authors report no conflicts.
- Published
- 2023
- Full Text
- View/download PDF
24. Five special focuses of Hypertension Research: digital hypertension, home blood pressure-centered approach, renal denervation, Asians, for guidelines.
- Author
-
Kario K, Hoshide S, and Mogi M
- Subjects
- Humans, Blood Pressure, Kidney, Denervation, Sympathectomy, Blood Pressure Monitoring, Ambulatory, Antihypertensive Agents therapeutic use, Treatment Outcome, Hypertension
- Published
- 2023
- Full Text
- View/download PDF
25. Home blood pressure-centered approach - from digital health to medical practice: HOPE Asia Network consensus statement 2023.
- Author
-
Kario K, Tomitani N, Wang TD, Park S, Li Y, Shin J, Tsoi K, Chen CH, Cheng HM, Siddique S, Turana Y, Buranakitjaroen P, Van Huynh M, Nailes J, Sison J, Soenarta AA, Sogunuru GP, Sukonthasarn A, Tay JC, Teo BW, Verma N, Zhang Y, Schlaich M, Nagai M, Fujiwara T, Hoshide S, Chia YC, and Wang JG
- Subjects
- Humans, Blood Pressure, Blood Pressure Determination methods, Blood Pressure Monitoring, Ambulatory, Asia, Hypertension diagnosis, Hypertension therapy
- Abstract
Recent innovations in digital technology have enabled the simultaneous accumulation, and the linking and analysis of time-series big data relating to several factors that influence blood pressure (BP), including biological indicators, physical activity, and environmental information. Various approaches can be used to monitor BP: in the office/clinic; at home; 24-h ambulatory recording; or with wearable and cuffless devices. Of these, home BP monitoring is a reliable and convenient method, and is recommended for hypertension management by current national and international guidelines. This recommendation is based on evidence showing that home BP is an important predictor of cardiovascular, cerebrovascular and kidney disease in patients with hypertension. In addition, lifetime personalized health record (PHR)-based home BP with telemonitoring combined with co-interventions has been shown to lower BP more effectively than the traditional approach based on office BP. Thus, home BP represents a key metric for personalized anticipation medicine, from digital healthcare to digital medicine. This paper summarizes the latest evidence on home BP monitoring and proposes a Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network consensus on a home BP-centered approach to the management of hypertension., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
26. Optimal blood pressure and improvement of achievement rate.
- Author
-
Mogi M, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Antihypertensive Agents therapeutic use, Antihypertensive Agents pharmacology, Hypertension drug therapy
- Published
- 2023
- Full Text
- View/download PDF
27. Different Home Blood Pressure Thresholds to Predict Perfect 24-Hour Ambulatory Blood Pressure Control in Treated Hypertension Based on an "All-in-One" Device.
- Author
-
Kario K, Tomitani N, Hoshide S, Nishizawa M, Yoshida T, Kabutoya T, Fujiwara T, Mizuno H, Okawara Y, and Kanegae H
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Determination, Prospective Studies, Blood Pressure Monitoring, Ambulatory, Hypertension diagnosis, Hypertension drug therapy, Hypertension epidemiology
- Abstract
Background: Home blood pressure (BP) is an important component of digital strategies for hypertension management. However, no studies have used the same device to investigate 24-hour BP control status in relation to different home BP control thresholds., Methods: Participants in the general practitioner-based, multicenter HI-JAMP study (Home-Activity Information and Communication Technology-Based Japan Ambulatory Blood Pressure Monitoring Prospective) underwent office BP measurement, then 24-hour ambulatory BP monitoring, then home BP monitoring for 5 days. A validated all-in-one BP monitoring device was used to measure office, home, and ambulatory BP. Baseline data were used to investigate ambulatory BP control status in individuals with well-controlled home BP based on the different guideline thresholds (125/75 mm Hg, 130/80 mm Hg, and 135/85 mm Hg)., Results: Data from 2269 patients were analyzed. For individuals with well-controlled home BP <135/85 mm Hg (59.5% of the total population), the prevalence of uncontrolled 24-hour (≥130/80 mm Hg), daytime (≥135/85 mm Hg), and nighttime ambulatory BP (≥120/70 mm Hg) was 19.9%, 18.5%, and 33.6%, respectively. Corresponding prevalence rates in the 42.7% of participants with well-controlled home BP <130/80 mm Hg were 13.4%, 12.9%, and 26.0%, and when well-controlled home BP was strictly defined as <125/75 mm Hg (23.9% of the population), prevalence of rates of uncontrolled 24-hour, daytime, and nighttime ambulatory BP were 7.0%, 9.0%, and 15.3%, respectively., Conclusions: Home BP control status defined using different thresholds could predict 24-hour ambulatory BP control status in treated hypertension. One-third of individuals still had uncontrolled nocturnal hypertension when home BP was controlled to <135/85 mm Hg, but ambulatory BP was quite well controlled when home BP was <125/75 mm Hg., Competing Interests: Disclosures K. Kario has received research grants from Omron Healthcare Co., Ltd., A&D Co., Ltd., and Fukuda Denshi Co., Ltd., and M. Nishizawa has received honoraria for lectures from Daiichi-Sankyo Co., Ltd. and Novartis Pharma K.K., T. Kabutoya has received scholarship funding from Abbott Co., Ltd. The other authors report no conflicts.
- Published
- 2023
- Full Text
- View/download PDF
28. Evening home blood pressure and pulse rate: age-specific associations with nocturia severity.
- Author
-
Nagai M, Hoshide S, and Kario K
- Subjects
- Humans, Male, Middle Aged, Aged, Female, Blood Pressure physiology, Heart Rate, Blood Pressure Monitoring, Ambulatory, Age Factors, Circadian Rhythm physiology, Nocturia diagnosis, Nocturia complications, Hypertension
- Abstract
Previous studies have reported a significant relationship between hypertension and nocturia. However, the underlying pathophysiology associated with pulse rate (PR) remains unclear. In the Japan Morning Surge-Home Blood Pressure Study, a self-administered nocturia questionnaire and evening home blood pressure (BP) and PR measurements (taken on a mean of 11.2 days) were performed on 4310 patients with one or more cardiovascular risk factors (mean: 64.9 years old; 47% male). According to the number of nighttime voids, the study population was divided into three groups (no voids: n = 2382; 1 void: n = 847; ≥2 voids per night: n = 1082). In the multinomial logistic regression analysis adjusted for confounders, diuretic use (OR, 1.23; 95%CI, 1.01-1.50; p < 0.05) was significantly associated with one nocturnal void, whereas evening home systolic BP (SBP) (OR per 1 SD, 1.14; 95%CI, 1.05-1.24; p < 0.01) and evening home PR (OR per 1 SD, 1.12; 95%CI: 1.02-1.24; p < 0.05) were significantly associated with multiple nocturnal voids. In the younger group (<65 years), only evening home PR was significantly related to multiple nighttime voids (p < 0.01), whereas in the older group (≥65 years), only evening home SBP was significantly related to multiple nighttime voids (p = 0.02). In this study, both higher evening home PR and higher evening home SBP were associated with multiple nighttime voids, with the former playing a greater role in the younger participants, and the latter more often associating the older group. An age-stratified approach to reduce the burden of BP or PR might be important to improve sleep quality., (© 2023. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
29. How do we tackle nighttime blood pressure?
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Circadian Rhythm physiology, Blood Pressure Monitoring, Ambulatory, Hypertension drug therapy
- Published
- 2023
- Full Text
- View/download PDF
30. What impacts do the new ESH 2023 guidelines have on the management of hypertension in Japan?
- Author
-
Kario K, Hoshide S, Mogi M, Nishiyama A, Ohya Y, and Node K
- Subjects
- Humans, Japan, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Hypertension drug therapy
- Published
- 2023
- Full Text
- View/download PDF
31. Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended.
- Author
-
Kario K, Tomitani N, Fujiwara T, Okawara Y, Kanegae H, and Hoshide S
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Monitoring, Ambulatory, Risk Factors, Hypertension complications, Coronary Artery Disease complications, Stroke epidemiology, Stroke etiology
- Abstract
While home blood pressure (BP) measurement is recommended for hypertension management, the clinical implications of peak home BP values have not been well studied. This study investigated the association between pathological threshold or frequency of peak home BP and cardiovascular events in patients with ≥1 cardiovascular risk factor. The Japan Morning Surge-Home Blood Pressure (J-HOP) study enrolled participants from 2005-2012 with extended follow-up from December 2017 to May 2018, which generated the dataset for this analysis. Average peak home systolic BP (SBP) was defined as average of the highest three BP values on 14-day measurement period. Patients were divided into quintiles of peak home BP, and the risk of stroke, coronary artery disease (CAD) and atherosclerotic cardiovascular disease (ASCVD; stroke+CAD) was determined. In 4231 patients (mean 65 years) followed for 6.2 years there were 94 strokes and 124 CAD events. The adjusted hazard ratio (HR) (95% CI) for the risk of stroke and ASCVD in patients with average peak home SBP in the highest versus lowest quintile was 4.39 (1.85-10.43) and 2.04 (1.24-3.36), respectively. Risk was greatest for stroke in the first 5 years: HR 22.66 (2.98-172.1). The pathological threshold of average peak home SBP for 5-year stroke risk was 176 mmHg. There was a linear association between the number of times peak home SBP > 175 mmHg and stroke risk. Peak home BP was a strong risk factor for stroke, especially within the first 5 years. We propose exaggerated peak home SBP > 175 mmHg as an early and strong novel risk factor for stroke., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
32. Novel blood pressure monitoring methods: perspectives for achieving "perfect 24-h blood pressure management".
- Author
-
Tomitani N, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Monitors, Prospective Studies, Blood Pressure Determination, Blood Pressure Monitoring, Ambulatory, Hypertension diagnosis, Hypertension drug therapy, Hypertension physiopathology
- Published
- 2023
- Full Text
- View/download PDF
33. Determinants and clinical implication of hypertension from childhood to old age in Asian subjects.
- Author
-
Mogi M, Hoshide S, and Kario K
- Subjects
- Adolescent, Adult, Aged, Child, Humans, Middle Aged, Young Adult, Risk Factors, Asian statistics & numerical data, Hypertension ethnology, Hypertension therapy
- Published
- 2023
- Full Text
- View/download PDF
34. Impact of diabetic status and contribution of office and home blood pressure across diabetic status for cardiovascular disease: the J-HOP study.
- Author
-
Suzuki D, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Glycated Hemoglobin, Blood Glucose metabolism, Risk Factors, Cardiovascular Diseases, Prediabetic State, Diabetes Mellitus epidemiology, Hypertension
- Abstract
Few studies have investigated whether the prognostic power of home blood pressure (BP) for cardiovascular disease (CVD) events differs across subjects with different diabetic status. We used the dataset of the J-HOP (Japan Morning Surge-Home Blood Pressure) study, which enrolled patients having cardiovascular risks to investigate relationships between home BP and CVD events. We classified the patients as having diabetes mellitus (DM), prediabetes or normal glucose metabolism (NGM) as follows: for DM, a self-reported history of physician-diagnosed DM and/or use of DM medication, a fasting plasma glucose ≥126 mg/dL, a casual plasma glucose level ≥200 mg/dL or hemoglobin A1c (HbA1c) ≥6.5% (n = 1034); for prediabetes, HbA1c of 5.7-6.4% (n = 1167), and for NGM, those who remained (n = 2024). CVD outcome was defined as coronary artery disease, stroke or heart failure. During a median 6.2 ± 3.8 years of follow-up, 259 CVD events occurred. Analysis found both prediabetes (Unadjusted Hazard ratio [uHR], 1.43; 95% confidence interval [CI], 1.05-1.95), and DM (uHR, 2.13; 95% CI, 1.59-2.85) as risks of CVD compared to NGM. In DM, patients with a 10-mmHg elevation of office systolic BP (SBP) and morning home SBP had 16% and 14% higher risks for CVD events. In the prediabetes group, only an elevated morning home SBP conferred a risk of CVD events (uHR, 1.15; 95% CI, 1.00-1.31), but this association did not hold for the adjusted model. Like DM, prediabetes should be recognized as a risk for CVD events, albeit weakly. Elevated home BP contributes to increased CVD risk in diabetes. Our study demonstrated the impact of prediabetes and diabetes on CVD and the impact of office and home BP on CVD events in each group., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
35. Sympathetic nervous activation and hypertension.
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Sympathetic Nervous System, Hypertension
- Published
- 2023
- Full Text
- View/download PDF
36. Home blood pressure measurement: the original and the best for predicting the risk.
- Author
-
Mogi M, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Determination, Risk Factors, Cardiovascular Diseases diagnosis, Hypertension diagnosis, Diabetes Mellitus
- Published
- 2023
- Full Text
- View/download PDF
37. Topics 2023 in Hypertension Research leading to guidelines in Asia.
- Author
-
Kario K, Hoshide S, and Mogi M
- Subjects
- Humans, Asia, Hypertension
- Published
- 2023
- Full Text
- View/download PDF
38. Current situation of telemedicine research for cardiovascular risk in Japan.
- Author
-
Shibata S and Hoshide S
- Subjects
- Humans, Japan epidemiology, Artificial Intelligence, Risk Factors, Heart Disease Risk Factors, COVID-19, Cardiovascular Diseases epidemiology, Telemedicine, Hypertension epidemiology
- Abstract
Hypertension continues to be a principal risk factor for the occurrence of cardiovascular disorders, stroke, and kidney diseases. Although more than 40 million subjects suffer from hypertension in Japan, its optimal control is achieved only a subpopulation of patients, highlighting the need for novel approaches to manage this disorder. Toward the better control of blood pressure, the Japanese Society of Hypertension has developed the Future Plan, in which the application of the state-of-art information and communication technology, including web-based resources, artificial intelligence, and big data analysis, is considered as one of the promising solutions. In fact, the rapid advance of digital health technologies, as well as ongoing coronavirus disease 2019 pandemic, has triggered the structural changes in the healthcare system globally, increasing demand for the remote delivery of the medical services. Nonetheless, it is not entirely clear what evidence exists that support the widespread use of telemedicine in Japan. Here, we summarize the current status of telemedicine research, particularly in the field of hypertension and other cardiovascular risk factors. We note that there have been very few interventional studies in Japan that clearly showed the superiority or noninferiority of telemedicine over standard care, and that the methods of online consultation considerably varied among studies. Clearly, more evidence is necessary for wide implementation of telemedicine in hypertensive patients in Japan, and also those with other cardiovascular risk factors., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
39. Preface-Metabolic aspects of hypertension in Asia.
- Author
-
Mogi M, Hoshide S, and Kario K
- Subjects
- Humans, Asia epidemiology, Risk Factors, Hypertension epidemiology, Cardiovascular Diseases
- Published
- 2023
- Full Text
- View/download PDF
40. The clinical significance of home and office blood pressure in diabetic nephropathy.
- Author
-
Suzuki D, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Clinical Relevance, Blood Pressure Determination, Diabetic Nephropathies diagnosis, Hypertension physiopathology, Diabetes Mellitus
- Published
- 2023
- Full Text
- View/download PDF
41. Home blood pressure-lowering effect of digital therapeutics in hypertension: impact of body weight and salt intake.
- Author
-
Kario K, Tomitani N, Harada N, Okura A, Hisaki F, Tanigawa T, and Hoshide S
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Monitoring, Ambulatory, Body Weight, Hypertension, Sodium Chloride, Dietary
- Abstract
Lifestyle modifications, including body weight reduction and salt restriction, help reduce blood pressure (BP). This study investigated the effects of body mass index (BMI) and salt intake on home BP reductions in unmedicated patients with hypertension receiving guideline-based lifestyle modification from doctors (control group) or with the addition of a digital therapeutics intervention. Data from the HERB Digital Hypertension 1 (HERB-DH1) pivotal trial were analyzed. Home BP was measured for 7 days before each study visit (baseline, and 4/8/12 weeks). Body weight was measured at each visit and salt intake questionnaire was answered at baseline and 12 weeks. This analysis included 302 patients with sufficient home BP monitoring data (digital therapeutics: 156; control group: 146). The reduction in morning home SBP from baseline to 12 weeks was significantly greater in the digital therapeutics vs. control group for patients with baseline BMI ≥ 25 kg/m
2 and higher salt intake group (self-reported salt intake score ≥ 14) (-5.1 mmHg, p < 0.01). Patients in the digital therapeutics group who experienced a reduction in BMI and an improvement in salt intake score during the 12-week study also had a significantly greater reduction in morning home SBP compared with patients in the control group (-7.2 mmHg, p < 0.01). The digital therapeutic intervention reduced home BP the most in unmedicated patients with hypertension with high baseline BMI and salt intake score. Those with improvements in both BMI and salt intake during the digital therapeutics intervention achieved the greatest reduction in home BP vs. control.Clinical trial registration: Japan Registry of Clinical Trials (jRCT2032190148)., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)- Published
- 2023
- Full Text
- View/download PDF
42. The importance of lifestyle modification for hypertension in Asia.
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Life Style, Asia epidemiology, Hypertension epidemiology, Hypertension therapy
- Published
- 2023
- Full Text
- View/download PDF
43. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗.
- Author
-
Parati G, Bilo G, Kollias A, Pengo M, Ochoa JE, Castiglioni P, Stergiou GS, Mancia G, Asayama K, Asmar R, Avolio A, Caiani EG, De La Sierra A, Dolan E, Grillo A, Guzik P, Hoshide S, Head GA, Imai Y, Juhanoja E, Kahan T, Kario K, Kotsis V, Kreutz R, Kyriakoulis KG, Li Y, Manios E, Mihailidou AS, Modesti PA, Omboni S, Palatini P, Persu A, Protogerou AD, Saladini F, Salvi P, Sarafidis P, Torlasco C, Veglio F, Vlachopoulos C, and Zhang Y
- Subjects
- Humans, Blood Pressure, Clinical Relevance, Blood Pressure Determination, Blood Pressure Monitoring, Ambulatory, Hypertension diagnosis, Hypertension drug therapy, Hypertension complications, Coronary Artery Disease complications
- Abstract
Blood pressure is not a static parameter, but rather undergoes continuous fluctuations over time, as a result of the interaction between environmental and behavioural factors on one side and intrinsic cardiovascular regulatory mechanisms on the other side. Increased blood pressure variability (BPV) may indicate an impaired cardiovascular regulation and may represent a cardiovascular risk factor itself, having been associated with increased all-cause and cardiovascular mortality, stroke, coronary artery disease, heart failure, end-stage renal disease, and dementia incidence. Nonetheless, BPV was considered only a research issue in previous hypertension management guidelines, because the available evidence on its clinical relevance presents several gaps and is based on heterogeneous studies with limited standardization of methods for BPV assessment. The aim of this position paper, with contributions from members of the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and from a number of international experts, is to summarize the available evidence in the field of BPV assessment methodology and clinical applications and to provide practical indications on how to measure and interpret BPV in research and clinical settings based on currently available data. Pending issues and clinical and methodological recommendations supported by available evidence are also reported. The information provided by this paper should contribute to a better standardization of future studies on BPV, but should also provide clinicians with some indications on how BPV can be managed based on currently available data., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
44. The combination of nondipper pulse rate pattern and nighttime high pulse rate variability is associated with an increase of brain natriuretic peptide: the J-HOP study.
- Author
-
Kabutoya T, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure, Heart Rate, Sleep, Circadian Rhythm, Blood Pressure Monitoring, Ambulatory, Natriuretic Peptide, Brain, Hypertension
- Abstract
The association between pulse rate (PR) and short-term PR variability and hypertensive organ damage has not been clarified. We enrolled 1439 patients from the J-HOP study. We calculated the standard deviation (SD) of PR in the nighttime using nighttime PR measurements at 30-min intervals. The SDs of PR (PR-SD) at nighttime were divided into quartiles (Q1-Q4). Nondipper PR was defined as (awake PR-sleep PR) < 0.1. Brain natriuretic peptide (BNP) levels were higher in patients with nondipper PR status in Q4 of PR-SD (nondipper PR/PR-SD Q4) than those with nondipper PR/PR-SD Q1-Q3 (37.8 vs 21.9 pg/mL, p = 0.041). The percentage of BNP > 100 pg/mL for patients with dipper PR/PR-SD Q1-Q3 was 5.2%, that for dipper PR/PR-SD Q4 was 4.8%, that for nondipper PR/PR-SD Q1-Q3 was 13.0%, and that for nondipper PR/PR-SD Q4 was 20.0% (ANOVA p < 0.001). In conclusion, BNP was high in patients having nondipper PR and high nocturnal PR-SD. Conceptual figure of subclinical heart failure and nondipper PR, PR variability. PR: pulse rate., (© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
45. Short- to long-term blood pressure variability: Current evidence and new evaluations.
- Author
-
Narita K, Hoshide S, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Monitoring, Ambulatory, Hypertension, Autonomic Nervous System Diseases, Prehypertension complications
- Abstract
Increased blood pressure (BP) variability and the BP surge have been reported to be associated with increased cardiovascular risk independently of BP levels and can also be a trigger of cardiovascular events. There are multiple types of BP variation: beat-to-beat variations related to breathing and the autonomic nervous system, diurnal BP variation and nocturnal dipping related to sleep and physical activity over a 24-hr period, day-to-day BP variability with anomalous readings within a several-day period, visit-to-visit BP variability between outpatient visits, and seasonal variations. BP variability is also associated with the progression to hypertension from prehypertension and the progression of chronic kidney disease and cognitive impairments. Our research group proposed the "resonance hypothesis of blood pressure surge" as a new etiological hypothesis of BP variability and surges; i.e., the concept that when the time phases of surges and hypertension-inducing environmental influences coincide, resonance occurs and is amplified into a larger "dynamic surge" that triggers the onset of cardiovascular disease. New devices to assess BP variability as well as new therapeutic interventions to reduce BP variability are being developed. Although there are still issues to be addressed (including measurement accuracy), cuffless devices and information and communication technology (ICT)-based BP monitoring devices have been developed and validated. These new devices will be useful for the individualized optimal management of BP. However, evidence regarding the usefulness of therapeutic interventions to control BP variability is still lacking., (© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
46. Difference between morning and evening blood pressure at home and nocturnal hypoxia in the general practitioner-based J-HOP study.
- Author
-
Hoshide S, Kubota K, and Kario K
- Subjects
- Humans, Blood Pressure physiology, Blood Pressure Monitoring, Ambulatory, Hypoxia, Circadian Rhythm physiology, Hypertension, General Practitioners
- Abstract
The aim of this study was to determine the independent association of nocturnal hypoxia with morning minus evening home blood pressure (MEdif) in a cohort of outpatients with at least one cardiovascular risk. A total of 1053 participants underwent home blood pressure (BP) portable pulse oximetry measurements, and 147 (14%) had an MEdif ≥20 mmHg, where MEdif was defined as the difference between morning and evening home systolic BP. When participants were divided into quartiles according to the lowest oxygen saturation (SpO
2 ) during the nighttime, those in the lowest quartile (range, 54-79%) were significantly more likely to have MEdif ≥20 mmHg than those in the top quartile (range, 89-97%) (adjusted odds ratio, 1.98; 95% confidence interval, 1.13-3.49). The present study revealed an association between lowest SpO2 during the nighttime and increased MEdif in a cohort of outpatients with at least one cardiovascular risk., (© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)- Published
- 2023
- Full Text
- View/download PDF
47. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19.
- Author
-
Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, Hoshide S, Mukoyama M, Kario K, Node K, and Rakugi H
- Subjects
- Humans, Post-Acute COVID-19 Syndrome, Quality of Life, SARS-CoV-2, COVID-19 complications, Hypertension
- Abstract
The coronavirus disease 2019 (COVID-19) affects infected patients even after the acute phase and impairs their health and quality of life by causing a wide variety of symptoms, referred to as long COVID. Although the evidence is still insufficient, hypertension is suspected to be a potential risk factor for long COVID, and the occurrence of cardiovascular diseases seems to be a key facet of multiple conditions observed in long COVID. Nonetheless, there are few reports that comprehensively review the impacts of long COVID on hypertension and related disorders. As a sequel to our previous report in 2020 which reviewed the association of COVID-19 and hypertension, we summarize the possible influences of long COVID on hypertension-related organs, including the cardiovascular system, kidney, and endocrine system, as well as the pathophysiological mechanisms associated with the disorders in this review. Given that the clinical course of COVID-19 is highly affected by age and sex, we also review the impacts of these factors on long COVID. Lastly, we discuss areas of uncertainty and future directions, which may lead to better understanding and improved prognosis of clinical problems associated with COVID-19., (© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
48. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19.
- Author
-
Shibata S, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, Hoshide S, Kishi T, Matsumoto C, Mogi M, Morimoto S, Yamamoto K, Mukoyama M, Kario K, Node K, and Rakugi H
- Subjects
- Humans, COVID-19 Vaccines, Pandemics, Post-Acute COVID-19 Syndrome, Renin-Angiotensin System, SARS-CoV-2, COVID-19 complications, Hypertension complications
- Abstract
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded 620 million worldwide, still having a profound impact on people's health and daily lives since its occurrence and outbreak in December 2019. From the early phase of the COVID-19 pandemic, there has been a concern that the rapid spread of this communicable disease can negatively influence non-communicable diseases. Accumulating data indicate that the restriction on the access to medical care, psychological distress, and life-style changes triggered by the pandemic have indeed affected blood pressure control in hypertensive patients. Since our previous report in 2020 that summarized the findings of the literature related to COVID-19 and hypertension, there has been a considerable progress in our understanding of the association between these two disorders; nonetheless, there are remaining challenges and emerging questions in the field. In this article, we aim to summarize the latest information on the impact of the pandemic on blood pressure control, the use of the renin-angiotensin system inhibitors in patients with COVID-19, and the blood pressure changes as one of the possible post-acute sequelae of COVID-19 (also known as long COVID). We also summarize the evidence of telemedicine and COVID-19 vaccination in hypertensive subjects, based on data available as of June 2022., (© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
49. Inconsistent Control Status of Office, Home, and Ambulatory Blood Pressure All Taken Using the Same Device: The HI-JAMP Study Baseline Data.
- Author
-
Kario K, Hoshide S, Tomitani N, Nishizawa M, Yoshida T, Kabutoya T, Fujiwara T, Mizuno H, Narita K, Komori T, Ogata Y, Suzuki D, Ogoyama Y, Ono A, Yamagiwa K, Abe Y, Nakazato J, Nakagawa N, Katsuya T, Harada N, and Kanegae H
- Subjects
- Humans, Blood Pressure, Blood Pressure Monitoring, Ambulatory methods, Blood Pressure Determination methods, Hypertension diagnosis, Hypertension drug therapy, White Coat Hypertension diagnosis
- Abstract
Background: Inconsistencies between the office and out-of-office blood pressure (BP) values (described as white-coat hypertension or masked hypertension) may be attributable in part to differences in the BP monitoring devices used., Methods: We studied consistency in the classification of BP control (well-controlled BP vs. uncontrolled BP) among office, home, and ambulatory BPs by using a validated "all-in-one" BP monitoring device. In the nationwide, general practitioner-based multicenter HI-JAMP study, 2,322 hypertensive patients treated with antihypertensive drugs underwent office BP measurements and 24-hour ambulatory BP monitoring (ABPM), consecutively followed by 5-day home BP monitoring (HBPM), for a total of seven BP measurement days., Results: Using the thresholds of the JSH2019 and ESC2018 guidelines, the patients with consistent classification of well-controlled status in the office (<140 mmHg) and home systolic BP (SBP) (<135 mmHg) (n = 970) also tended to have well-controlled 24-hour SBP (<130 mmHg) (n = 808, 83.3%). The patients with the consistent classification of uncontrolled status in office and home SBP (n = 579) also tended to have uncontrolled 24-hour SBP (n = 444, 80.9%). Among the patients with inconsistent classifications of office and home BP control (n = 803), 46.1% had inconsistent ABPM-vs.-HBPM out-of-office BP control status. When the 2017 ACC/AHA thresholds were applied as an alternative, the results were essentially the same., Conclusions: The combined assessment of the office and home BP is useful in clinical practice. Especially for patients whose office BP classification and home BP classification conflict, the complementary clinical use of both HBPM and ABPM might be recommended., (© The Author(s) 2022. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
50. Target organ damage for the management of hypertension in the Asian population.
- Author
-
Hoshide S, Mogi M, and Kario K
- Subjects
- Humans, Blood Pressure, Hypertension drug therapy, Hypertension epidemiology, Cardiovascular Diseases
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.